Clinical Trial Update: Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of desensitization therapy in sensitized patients awaiting heart transplantation; the study was terminated and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Heart Failure
• Heart Failure

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Primary Heart Transplant, Heart Transplantation | Phase 2 | Status: TERMINATED | Results posted: 2015-11-11